Moneypox Outbreak Puts Focus On These Two Biotechs
Just when you thought it was safe to go outside, monkeypox pops up. This might not be bad news for the market, as the world… Read More »Moneypox Outbreak Puts Focus On These Two Biotechs
Biopharma Stocks
Sympathy Moves On Biogen’s Big News
Big news for one stock can result in sympathy moves for other stocks. So, in the wake of big news for Biogen with the FDA… Read More »Sympathy Moves On Biogen’s Big News
A Defiant ETF Bet
Biotech stocks have been retreating, as have small-cap stocks. But this ETF at the intersection of both could still be a great bet. CLICK HERE.
2 Clinical-Stage Biopharma Stocks With Triple-Digit Upside Potential
Analysts at Wells Fargo – and the broader analyst community – see triple-digit upside potential in these two stocks, both clinical-stage biopharmaceutical companies. CLICK HERE.